In: Critical care, 16 (2012), Nr. R140. S. 1-9. ISSN 1466-609X
Vorschau |
PDF, Englisch
Download (529kB) | Lizenz: Creative Commons Namensnennung 3.0 Deutschland |
Abstract
Introduction: Acute kidney injury (AKI) is associated with a high mortality of up to 60%. The mode of renal replacement therapy (intermittent versus continuous) has no impact on patient survival. Sustained low efficiency dialysis using a single-pass batch dialysis system (SLED-BD) has recently been introduced for the treatment of dialysis-dependent AKI. To date, however, only limited evidence is available in the comparison of SLED-BD versus continuous veno-venous hemofiltration (CVVH) in intensive care unit (ICU) patients with AKI. Methods: Prospective, randomized, interventional, clinical study at a surgical intensive care unit of a university hospital. Between 1 April 2006 and 31 January 2009, 232 AKI patients who underwent renal replacement therapy (RRT) were randomized in the study. Follow-up was assessed until 30 August 2009. Patients were either assigned to 12-h SLED-BD or to 24-h predilutional CVVH. Both therapies were performed at a blood flow of 100 to 120 ml/min. Results: 115 patients were treated with SLED-BD (total number of treatments n = 817) and 117 patients with CVVH (total number of treatments n = 877).The primary outcome measure, 90-day mortality, was similar between groups (SLED: 49.6% vs. CVVH: 55.6%, P = 0.43). Hemodynamic stability did not differ between SLED-BD and CVVH, whereas patients in the SLED-BD group had significantly fewer days of mechanical ventilation (17.7 ± 19.4 vs. 20.9 ± 19.8, P = 0.047) and fewer days in the ICU (19.6 ± 20.1 vs. 23.7 ± 21.9, P = 0.04). Patients treated with SLED needed fewer blood transfusions (1,375 ± 2,573 ml vs. 1,976 ± 3,316 ml, P = 0.02) and had a substantial reduction in nursing time spent for renal replacement therapy (P < 0.001) resulting in lower costs. Conclusions: SLED-BD was associated with reduced nursing time and lower costs compared to CVVH at similar outcomes. In the light of limited health care resources, SLED-BD offers an attractive alternative for the treatment of AKI in ICU patients. Trial registration: ClinicalTrials.gov NCT00322530
Dokumententyp: | Artikel |
---|---|
Titel der Zeitschrift: | Critical care |
Band: | 16 |
Nummer: | R140 |
Verlag: | BioMed Central; Springer |
Ort der Veröffentlichung: | London; Berlin; Heidelberg |
Erstellungsdatum: | 18 Aug. 2016 13:20 |
Erscheinungsjahr: | 2012 |
ISSN: | 1466-609X |
Seitenbereich: | S. 1-9 |
Institute/Einrichtungen: | Zentrale und Sonstige Einrichtungen > Nierenzentrum Heidelberg
Medizinische Fakultät Heidelberg und Uniklinikum > Medizinische Universitäts-Klinik und Poliklinik Medizinische Fakultät Heidelberg und Uniklinikum > Universitätsklinik für Anaesthesiologie |
DDC-Sachgruppe: | 610 Medizin |